1. Home
  2. HYMC vs POM Comparison

HYMC vs POM Comparison

Compare HYMC & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYMC
  • POM
  • Stock Information
  • Founded
  • HYMC N/A
  • POM 2015
  • Country
  • HYMC United States
  • POM China
  • Employees
  • HYMC 56
  • POM N/A
  • Industry
  • HYMC Precious Metals
  • POM Other Specialty Stores
  • Sector
  • HYMC Basic Materials
  • POM Consumer Discretionary
  • Exchange
  • HYMC Nasdaq
  • POM Nasdaq
  • Market Cap
  • HYMC 648.5M
  • POM 556.7M
  • IPO Year
  • HYMC N/A
  • POM 2025
  • Fundamental
  • Price
  • HYMC $7.75
  • POM $5.06
  • Analyst Decision
  • HYMC
  • POM
  • Analyst Count
  • HYMC 0
  • POM 0
  • Target Price
  • HYMC N/A
  • POM N/A
  • AVG Volume (30 Days)
  • HYMC 1.9M
  • POM 3.1M
  • Earning Date
  • HYMC 10-28-2025
  • POM 01-01-0001
  • Dividend Yield
  • HYMC N/A
  • POM N/A
  • EPS Growth
  • HYMC N/A
  • POM N/A
  • EPS
  • HYMC N/A
  • POM N/A
  • Revenue
  • HYMC N/A
  • POM $46,931,528.00
  • Revenue This Year
  • HYMC N/A
  • POM N/A
  • Revenue Next Year
  • HYMC N/A
  • POM N/A
  • P/E Ratio
  • HYMC N/A
  • POM N/A
  • Revenue Growth
  • HYMC N/A
  • POM 12.37
  • 52 Week Low
  • HYMC $1.99
  • POM $3.47
  • 52 Week High
  • HYMC $9.75
  • POM $5.04
  • Technical
  • Relative Strength Index (RSI)
  • HYMC 56.21
  • POM N/A
  • Support Level
  • HYMC $6.48
  • POM N/A
  • Resistance Level
  • HYMC $8.26
  • POM N/A
  • Average True Range (ATR)
  • HYMC 0.71
  • POM 0.00
  • MACD
  • HYMC -0.11
  • POM 0.00
  • Stochastic Oscillator
  • HYMC 40.99
  • POM 0.00

About HYMC Hycroft Mining Holding Corporation

Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: